Literature DB >> 20570380

Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation.

Ala Yaromina1, Howard Thames, Xuanjing Zhou, Sandra Hering, Wolfgang Eicheler, Annegret Dörfler, Thomas Leichtner, Daniel Zips, Michael Baumann.   

Abstract

OBJECTIVE: To investigate the relationships between radiobiological hypoxic fraction (rHF), pimonidazole hypoxic fraction (pHF) as well as other histological parameters of the tumour microenvironment, and local tumour control after fractionated irradiation in human squamous cell carcinomas (hSCCs).
MATERIAL AND METHODS: Ten different hSCC cell lines were transplanted into nude mice and rHF was calculated from local tumour control rates after single dose irradiation under normal or clamped blood flow conditions. In parallel, tumours were irradiated with 30 fractions within 6 weeks. Radiation response was quantified as dose required to cure 50% of tumours (TCD(50)). Unirradiated tumours were excised for histological evaluation including relative hypoxic area (pHF), relative vascular area (RVA), and fraction of perfused vessels (PF).
RESULTS: A weak but significant positive correlation between rHF (R(2)=0.6, p=0.014) and TCD(50) after fractionated irradiation was found. The pHF did not correlate with rHF but was significantly associated with the TCD(50) after single dose clamp (R(2)=0.8, p=0.003) and showed a trend for an association with TCD(50) after fractionated irradiation (R(2)=0.4, p=0.067). Relative vascular area and fraction of perfused vessels did not show an association with rHF or TCD(50) after fractionated irradiation.
CONCLUSIONS: Our data suggest that radiobiological hypoxia contributes to the response after fractionated irradiation but that also other radiobiological mechanisms are involved. In the present study, pimonidazole labelling does not reflect rHF and has a limited value to predict local tumour control after fractionated irradiation. The association between pHF and TCD(50) after single dose clamp warrants further investigation. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570380     DOI: 10.1016/j.radonc.2010.04.020

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  23 in total

Review 1.  [Experimental tumor therapy].

Authors:  M Baumann; D Zips; M Krause
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

Review 2.  Profiles of Radioresistance Mechanisms in Prostate Cancer.

Authors:  Luksana Chaiswing; Heidi L Weiss; Rani D Jayswal; Daret K St Clair; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2018

Review 3.  The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivity.

Authors:  Guang-Zong Chen; Hong-Cheng Zhu; Wang-Shu Dai; Xiao-Ning Zeng; Jin-Hua Luo; Xin-Chen Sun
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

5.  E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells.

Authors:  Guido Lammering; Marc Vooijs; Jan Theys; Barry Jutten; Roger Habets; Kim Paesmans; Arjan J Groot; Philippe Lambin; Brad G Wouters
Journal:  Radiother Oncol       Date:  2011-06-15       Impact factor: 6.280

6.  Spatial oxygenation profiles in tumors during normo- and hyperbaric hyperoxia.

Authors:  Oliver Thews; Peter Vaupel
Journal:  Strahlenther Onkol       Date:  2015-07-02       Impact factor: 3.621

7.  High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.

Authors:  Liangfang Shen; Xinqiong Huang; Xiaoxue Xie; Juan Su; Jun Yuan; Xiang Chen
Journal:  J Histochem Cytochem       Date:  2014-04-07       Impact factor: 2.479

8.  Prognostic value of radiobiological hypoxia during fractionated irradiation for local tumor control.

Authors:  Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

Review 9.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

10.  Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models.

Authors:  Hanneke Stegeman; Johannes H Kaanders; Albert J van der Kogel; Mari Iida; Deric L Wheeler; Paul N Span; Johan Bussink
Journal:  Radiother Oncol       Date:  2013-02-28       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.